The Enriched Citation API provides the Intellectual Property 5 (IP5 - EPO, JPO, KIPO, CNIPA, and USPTO) and the Public with greater insight into the patent evaluation process. It allows users to quickly view information about which references, or prior art, were cited in specific patent application Office Actions, including: bibliographic information of the reference, the claims that the prior art was cited against, and the relevant sections that the examiner relied upon.

The Enriched Citation API provides the Intellectual Property 5 (IP5 - EPO, JPO, KIPO, CNIPA, and USPTO) and the Public with greater insight into the patent evaluation process. It allows users to quickly view information about which references, or prior art, were cited in specific patent application Office Actions, including: bibliographic information of the reference, the claims that the prior art was cited against, and the relevant sections that the examiner relied upon.

SRM 2969 Electronic files containing certified values and their uncertainties, and the data used to assign those values

Electronic files containing certified values and their uncertainties, and the data used to assign those values.

The National Institute of Standards and Technology, Intelligent Systems Division has collected data measuring human subjects, while performing common, simulated industrial manufacturing tasks with and without wearing an exoskeleton. Five tests were completed as part of a research study to develop measurement science towards standard test methods. For simulated industrial manufacturing tasks were performed using a novel, now standardized apparatus, called the Position and Load Test Apparatus for Exoskeletons (PoLoTAE).

These LC-MS and LC-MS/MS raw data were collected for purposes of an interlaboratory study evaluating the multi-attribute method (MAM). Tryptic digests of native NISTmAb (the "Reference" and the "Unknown" samples), degraded NISTmAb (the "pH Stress" sample) and NISTmAb spiked with 15 heavy-labeled synthetic peptides (the "Spike" sample) were sent to each participating laboratory. One injection of each digest was acquired in MS-only mode, while a second injection was acquired in MS/MS mode.

The Intellectual Property (IP) Marketplace Platform, also called Patents 4 Partnerships is an initiative of the U.S. Patent and Trademark Office (USPTO) that brings together those who have technologies and want to make them available for licensing and those who have an interest in and the ability to commercialize the technologies. The IP Marketplace Platform provides a voluntary listing of patents and patent application publications (pre-grant publications, pgpubs) indicated as *available for licensing* on external public websites or in the USPTO Patent Official Gazette Notices.

Contains detailed information derived from the Office actions issued by patent examiners to applicants during the patent examination process. The Office Action is a written notification to the applicant of the examiners decision on patentability. It generally discloses the reasons for any rejections, objections, or requirements and includes relevant information or references that the applicant may find useful for responding to the examiner and deciding whether to continue prosecuting the application.

Contains detailed information derived from the Office actions issued by patent examiners to applicants during the patent examination process. The Office Action is a written notification to the applicant of the examiners decision on patentability. It generally discloses the reasons for any rejections, objections, or requirements and includes relevant information or references that the applicant may find useful for responding to the examiner and deciding whether to continue prosecuting the application.

The Office Action Retrieval API provides access to the full-text information of Office Actions (bundled as a JSON file in downloadable weekly zip files) issued by patent examiners to applicants during the patent examination process. The Office Action is a written notification to the applicant of the examiners decision on patentability. It generally discloses the reasons for any rejections, objections, or requirements and includes relevant information or references that the applicant may find useful for responding to the examiner and deciding whether to continue prosecuting the application.